Read time: 3 minutes
Mental health concerns such as anxiety, difficulty concentrating, emotional dysregulation, and sleep disturbance often emerge early in childhood and adolescence. While these symptoms may not always meet criteria for a formal psychiatric diagnosis or require medication, they can still significantly affect a child’s wellbeing, relationships, and developmental trajectory.
In pediatric practice, families frequently ask about natural or lower-risk options—particularly when symptoms are mild, intermittent, or when they are hesitant to pursue conventional pharmacologic treatment. Herbal medicine is often part of this discussion, yet clear, evidence-based guidance for pediatric use has historically been limited. A growing body of research is beginning to address this gap, offering insight into which botanicals may be helpful, how they may work, and where they fit within integrative pediatric care.
A recent systematic review published in Biomedicines analyzed 29 clinical trials evaluating herbal and botanical interventions for psychological and behavioral symptoms in children and adolescents. The review included studies involving both formal psychiatric diagnoses—such as ADHD, anxiety disorders, and depression—as well as more common symptom presentations including restlessness, agitation, nervousness, and sleep difficulties. The authors examined products categorized as either registered herbal medicines or food supplements, and incorporated bioinformatic modeling to explore potential pharmacologic mechanisms relevant to pediatric mental health.
The review evaluated a range of commonly used botanicals in pediatric and integrative practice, including:
Several of these herbs demonstrated preliminary evidence for supporting anxiety, sleep quality, or attention—particularly in children with mild to moderate symptom profiles. However, study quality and outcome measures varied considerably.
Lavender oil, administered via inhalation, showed the most consistent results, especially for reducing situational anxiety during medical or procedural settings. Bacopa monnieri and saffron demonstrated promising effects in small ADHD trials, where children experienced improvements in attention and behavioral regulation.
Across studies, most herbal interventions were generally well tolerated, with few serious adverse events reported. That said, safety data was limited, and long-term outcomes were rarely assessed.
Using computational and network-based modeling, the authors explored how phytochemical constituents might influence neurological and psychological pathways. Their analysis suggested that many of these botanicals may:
These mechanisms offer plausible explanations for the observed calming, sleep-supportive, and attention-enhancing effects, though direct clinical correlations remain incomplete.
The review highlights several important limitations relevant to clinical interpretation. Many studies were small, short in duration, or lacked standardized dosing protocols. Outcome measures varied widely, and pediatric safety data—particularly for long-term use—remains insufficient.
The authors emphasize the need for larger, well-designed clinical trials to clarify dosing, safety, duration of use, and age-specific effects in pediatric populations.
Pediatric clinicians looking for evidence-based integrative insights can subscribe to Monday Study Rundown, a weekly summary of clinically relevant pediatric research with practical takeaways for real-world care.
For more Monday Study Rundowns, click here .
Looking to deepen your clinical toolkit?
